Protective effect of yerba mate intake on the cardiovascular system: a post hoc analysis study in postmenopausal women - PubMed (original) (raw)
Protective effect of yerba mate intake on the cardiovascular system: a post hoc analysis study in postmenopausal women
D T A da Veiga et al. Braz J Med Biol Res. 2018.
Abstract
The prevalence of cardiovascular and metabolic diseases is increased in postmenopausal women, which contributes to the burden of illnesses in this period of life. Yerba mate (Ilex paraguariensis) is a native bush from Southern South America. Its leaves are rich in phenolic components, which may have antioxidant, vasodilating, hypocholesterolemic, and hypoglycemic proprieties. This post hoc analysis of the case-control study nested in the Obesity and Bone Fracture Cohort evaluated the consumption of yerba mate and the prevalence of hypertension, dyslipidemia, and coronary diseases in postmenopausal women. Ninety-five postmenopausal women were included in this analysis. A questionnaire was applied to evaluate the risk factors and diagnosis of cardiovascular diseases and consumption of yerba mate infusion. Student's t-test and chi-square test were used to assess significant differences between groups. The group that consumed more than 1 L/day of mate infusion had significantly fewer diagnoses of coronary disease, dyslipidemia, and hypertension (P<0.049, P<0.048, and P<0.016, respectively). Furthermore, the serum levels of glucose were lower in the group with a higher consumption of yerba mate infusion (P<0.013). The serum levels of total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides were similar between the groups. This pragmatic study points out the benefits of yerba mate consumption for the cardiovascular and metabolic systems. The ingestion of more than 1 L/day of mate infusion was associated with fewer self-reported cardiovascular diseases and lower serum levels of glucose. Longitudinal studies are needed to evaluate the association between yerba mate infusion and reduction of cardiovascular diseases in postmenopausal women.
Similar articles
- The yerba mate intake has a neutral effect on bone: A case-control study in postmenopausal women.
da Veiga DTA, Bringhenti R, Bolignon AA, Tatsh E, Moresco RN, Comim FV, Premaor MO. da Veiga DTA, et al. Phytother Res. 2018 Jan;32(1):58-64. doi: 10.1002/ptr.5947. Epub 2017 Oct 13. Phytother Res. 2018. PMID: 29027270 - Consumption of yerba mate ( Ilex paraguariensis ) improves serum lipid parameters in healthy dyslipidemic subjects and provides an additional LDL-cholesterol reduction in individuals on statin therapy.
de Morais EC, Stefanuto A, Klein GA, Boaventura BC, de Andrade F, Wazlawik E, Di Pietro PF, Maraschin M, da Silva EL. de Morais EC, et al. J Agric Food Chem. 2009 Sep 23;57(18):8316-24. doi: 10.1021/jf901660g. J Agric Food Chem. 2009. PMID: 19694438 Clinical Trial. - Yerba Mate (Ilex paraguariensis) consumption is associated with higher bone mineral density in postmenopausal women.
Conforti AS, Gallo ME, Saraví FD. Conforti AS, et al. Bone. 2012 Jan;50(1):9-13. doi: 10.1016/j.bone.2011.08.029. Epub 2011 Sep 3. Bone. 2012. PMID: 21920487 - Yerba Mate Tea (Ilex paraguariensis): a comprehensive review on chemistry, health implications, and technological considerations.
Heck CI, de Mejia EG. Heck CI, et al. J Food Sci. 2007 Nov;72(9):R138-51. doi: 10.1111/j.1750-3841.2007.00535.x. J Food Sci. 2007. PMID: 18034743 Review. - The positive effects of yerba maté (Ilex paraguariensis) in obesity.
Gambero A, Ribeiro ML. Gambero A, et al. Nutrients. 2015 Jan 22;7(2):730-50. doi: 10.3390/nu7020730. Nutrients. 2015. PMID: 25621503 Free PMC article. Review.
Cited by
- Changes in the Physicochemical and Bioactive Properties of Yerba Mate Depending on the Brewing Conditions.
Najman K, Rajewski R, Sadowska A, Hallmann E, Buczak K. Najman K, et al. Molecules. 2024 May 31;29(11):2590. doi: 10.3390/molecules29112590. Molecules. 2024. PMID: 38893465 Free PMC article. - Acute Supplementation of Yerba Mate Extract Did Not Change Muscle Strength in Physically Active Men Following the Strength Muscle Test: A Pilot Clinical Trial.
Lobo PCB, da Silva DD, Pimentel GD. Lobo PCB, et al. Nutrients. 2022 Jun 24;14(13):2619. doi: 10.3390/nu14132619. Nutrients. 2022. PMID: 35807800 Free PMC article. Clinical Trial. - Yerba Mate Modulates Tumor Cells Functions Involved in Metastasis in Breast Cancer Models.
Rocio Soledad GL, Lorena Gisel C, Norailys L, Humberto L, Daniel Fernando A, Hernan Gabriel F. Rocio Soledad GL, et al. Front Pharmacol. 2021 Nov 11;12:750197. doi: 10.3389/fphar.2021.750197. eCollection 2021. Front Pharmacol. 2021. PMID: 34858179 Free PMC article. - Yerba Mate-A Long but Current History.
Gawron-Gzella A, Chanaj-Kaczmarek J, Cielecka-Piontek J. Gawron-Gzella A, et al. Nutrients. 2021 Oct 21;13(11):3706. doi: 10.3390/nu13113706. Nutrients. 2021. PMID: 34835962 Free PMC article. Review. - Adipose tissue of female Wistar rats respond to Ilex paraguariensis treatment after ovariectomy surgery.
Rocha DS, Argenta Model JF, Von Dentz M, Maschio J, Ohlweiler R, Lima MV, Khal de Souza S, Sarapio E, Vogt ÉL, Waszczuk M, Martiny S, Bassani VL, Kucharski LC. Rocha DS, et al. J Tradit Complement Med. 2020 Aug 1;11(3):238-248. doi: 10.1016/j.jtcme.2020.07.002. eCollection 2021 May. J Tradit Complement Med. 2020. PMID: 34012870 Free PMC article.
References
- de Morais EC, Stefanuto A, Klein GA, Boaventura BC, de Andrade F, Wazlawik E, et al. Consumption of yerba mate (Ilex paraguariensis) improves serum lipid parameters in healthy dyslipidemic subjects and provides an additional LDL-cholesterol reduction in individuals on statin therapy. J Agric Food Chem. 2009;57:8316–8324. doi: 10.1021/jf901660g. - DOI - PubMed
- Messina D, Soto C, Mendez A, Corte C, Kemnitz M, Avena V, et al. [Lipid-lowering effect of mate tea intake in dyslipidemic subjects] Nutr Hosp. 2015;31:2131–2139. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical